Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS AND CONTINGENCIES (Details Narrative)

v3.22.2.2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Nov. 16, 2021
Sep. 30, 2022
Sep. 30, 2022
Jul. 31, 2022
Subsidiary, Sale of Stock [Line Items]        
Waived deferred underwriting fee   $ 240,082 $ 240,082  
Remaining underwriting fee outstanding   $ 2,099,501 2,099,501  
Retained Earnings [Member]        
Subsidiary, Sale of Stock [Line Items]        
Waived deferred underwriting fee     $ 4,658,753  
Underwriting Agreement [Member]        
Subsidiary, Sale of Stock [Line Items]        
Underwriter cash discount per unit $ 0.20      
Payment of underwriting commissions $ 3,999,049      
Deferred fee $ 0.35      
Deferred underwriting fee $ 6,998,336     $ 4,898,835
Over-Allotment Option [Member]        
Subsidiary, Sale of Stock [Line Items]        
Purchase of additional shares 2,495,246 2,625,000 2,625,000  
Offering price per share $ 10.00      
Proceeds from shares $ 24,952,460